Frankly Speaking About Family Medicine Podcast

Hosted ByPri-Med

Translating today's clinical research and news into tomorrow's practice.
Each episode of this podcast series, hosted by Frank J. Domino, MD, Professor in the Department of Family Medicine and Community Health at UMass Medical School, will feature interviews with family physicians about practice-changing clinical research and cover patient-focused best practices in Family Medicine.

Frankly Speaking About Family Medicine Boosting Weight Loss with Medications: New support for GLP-1 RAs – Frankly Speaking Ep 270

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-270

Overview: You know GLP-1 RAs are an important class of agents for weight loss, but do you know which drug within this class is right for your patient? This brief podcast walks you through the recent evidence from the STEP 8 randomized clinical trial, comparing the efficacy and adverse reaction profiles for 2 GLP-1 RAs: semaglutide (Wegovy) and liraglutide (Saxenda). This is a must-listen for anyone looking to optimally individualize care for patients with obesity.

Episode resource links:

  • Rubino DM, Greenway FL, Khalid U, et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138–150. doi:10.1001/jama.2021.23619

Guest: Jillian Joseph, MSPAS, PA-C
 
Music Credit: Richard Onorato

Deja una respuesta

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.